21,128 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) …

The fund acquired 21,128 shares of the company's sto. Fred Alger Management LLC acquired a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during …

0%
OFF

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought By

2 weeks from now

Dec 24, 2024 · Barclays PLC lifted its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 291.0% in the third quarter, according to the company in its most recent 13F …

marketbeat.com

332%
OFF

28,303 Shares In Edgewise Therapeutics, Inc. (NASDAQ:EWTX) …

2 weeks from now

Dec 12, 2024 · Edgewise Therapeutics Stock Performance. Analysts Think There's Still Time to Get in on Edgewise, Up 332%; Shares of NASDAQ EWTX opened at $29.80 on Thursday. …

marketbeat.com

0%
OFF

Edgewise Therapeutics (NASDAQ: EWTX) - The Motley Fool

2 weeks from now

Edgewise Therapeutics (NASDAQ: EWTX) $24.15 (-5.0%) -$1.27. Price as of January 10, 2025, 4:00 p.m. ET ... Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It …

fool.com

$3.12
OFF

Edgewise Therapeutics Inc Stock Price Today | NASDAQ: EWTX …

2 weeks from now

Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a $3.12 billion market cap biopharmaceutical company focused on developing therapies for severe, rare muscle disorders, is navigating a...

investing.com

$25
OFF

Edgewise Therapeutics Inc. - MarketWatch

2 weeks from now

Dec 16, 2024 · Edgewise Therapeutics Shares Rise on Positive Results for Heart-Disease Treatment Sep. 19, 2024 at 8:06 a.m. ET Edgewise Therapeutics started at buy with $25 stock …

marketwatch.com

$43.17
OFF

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $43.17 …

2 weeks from now

2 days ago · Edgewise Therapeutics stock opened at $25.33 on Friday. Edgewise Therapeutics has a 52 week low of $9.00 and a 52 week high of $38.12. The firm’s 50-day simple moving …

etfdailynews.com

4%
OFF

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 7.4

2 weeks from now

2 days ago · Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) traded up 7.4% during trading on Tuesday . The stock traded as high as $27.27 and last traded at …

marketbeat.com

332%
OFF

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus ...

2 weeks from now

5 days ago · Edgewise Therapeutics Stock Performance. Analysts Think There's Still Time to Get in on Edgewise, Up 332%; Shares of NASDAQ EWTX opened at $24.15 on Friday. The …

marketbeat.com

$0.36
OFF

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down

2 weeks from now

Jan 6, 2025 · Edgewise Therapeutics (NASDAQ:EWTX - Get Free Report) last released its quarterly earnings data on Thursday, November 7th.The company reported ($0.36) EPS for …

marketbeat.com

FAQs about 21,128 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) … Coupon?

What is the target price for Edgewise Therapeutics (ewtx)?

3 brokers have issued twelve-month target prices for Edgewise Therapeutics' shares. Their EWTX share price forecasts range from $5.00 to $29.00. On average, they predict the company's stock price to reach $17.00 in the next twelve months. This suggests a possible upside of 123.1% from the stock's current price. ...

Where can I buy Edgewise Therapeutics stock?

Shares of EWTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Edgewise Therapeutics' stock price today? ...

Where is Edgewise Therapeutics Inc headquartered?

The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO. EWTX | Complete Edgewise Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Is Edgewise a pharmaceutical company?

Market Open. Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. ...

What research coverage has Edgewise Therapeutics received?

Edgewise Therapeutics has received no research coverage in the past 90 days. Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. ...

Is Edgewise Therapeutics a potential M&A target?

Edgewise Therapeutics GAAP EPS of -$0.34 beats by $0.02 SA NewsThu, Aug. 08 Edgewise Therapeutics, Inc. SEC Filing - Quarterly Report (10-Q) August 08, 2024 SEC FilingsThu, Aug. 08 Viridian, Pharvaris said to be among prime M&A targets for Biogen SA NewsTue, Jul. 16 Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo ...